Halozyme Therapeutics
HALO
#2362
Rank
A$10.53 B
Marketcap
A$89.26
Share price
-0.60%
Change (1 day)
-11.65%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): A$1.15 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are A$1.24 Billion. In 2024 the company made an earning of A$0.78 Billion, an increase over its 2023 earnings that were of A$0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$1.15 B47.54%
2024 A$0.78 B59.94%
2023 A$0.49 B39.94%
2022 A$0.35 B0.16%
2021 A$0.35 B92.2%
2020 A$0.18 B-278.96%
2019 -A$0.11 Billion-9.45%
2018 -A$0.12 Billion-229.51%
2017 A$86.92 M-160.48%
2016 -A$0.15 Billion216.03%
2015 -A$45.48 Million-52.86%
2014 -A$96.47 Million-18.09%
2013 -A$0.12 Billion55.88%
2012 -A$75.56 Million169.94%
2011 -A$27.99 Million-63.44%
2010 -A$76.55 Million-7.19%
2009 -A$82.48 Million15.91%
2008 -A$71.16 Million83.89%
2007 -A$38.7 Million78.1%
2006 -A$21.73 Million16%
2005 -A$18.73 Million45.24%
2004 -A$12.9 Million682.42%
2003 -A$1.65 Million1659.12%
2002 -A$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.70 B 4,242.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$16.72 B 1,488.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$31.74 B 2,916.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$12.83 B 1,119.98%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-A$0.39 Billion-136.20%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$43.42 M-95.87%๐Ÿ‡บ๐Ÿ‡ธ USA